David Lucas Selected Research

Caspase 9

2/2002

The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Lucas Research Topics

Disease

8	Neoplasms (Cancer) 02/2024 - 02/2002
3	Hypertension (High Blood Pressure) 01/2022 - 01/2012
3	Poisoning 01/2020 - 01/2010
3	Sarcoma (Soft Tissue Sarcoma) 07/2015 - 04/2002
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2014 - 02/2002
2	Asthma (Bronchial Asthma) 12/2020 - 01/2010
2	Leukemia 01/2003 - 02/2002
1	Alveolar Soft Part Sarcoma 02/2024
1	Perivascular Epithelioid Cell Neoplasms 02/2024
1	Epithelioid Hemangioendothelioma 02/2024
1	Adrenocortical Carcinoma 02/2024
1	Clear Cell Sarcoma 02/2024
1	Granular Cell Tumor 02/2024
1	Rhabdomyosarcoma 02/2024
1	Renal Cell Carcinoma (Grawitz Tumor) 02/2024
1	Paraganglioma (Paragangliomas) 02/2024
1	Melanoma (Melanoma, Malignant) 02/2024
1	Plague (Bubonic Plague) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Carcinoma (Carcinomatosis) 04/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2020
1	Bronchial Diseases 12/2019
1	Solitary Fibrous Tumors 09/2015
1	Prostatic Neoplasms (Prostate Cancer) 09/2015
1	Lymphocytosis 03/2014
1	Overweight 01/2013
1	Headache (Headaches) 01/2010
1	Immediate Hypersensitivity 01/2010
1	Muscle Weakness 01/2010
1	Occupational Asthma 01/2010
1	Vomiting 01/2003
1	Nausea 01/2003
1	Fever (Fevers) 01/2003
1	Margins of Excision 10/2002
1	Hemangiosarcoma (Angiosarcoma) 04/2002
1	Breast Neoplasms (Breast Cancer) 04/2002
1	Second Primary Neoplasms (Neoplasms, Second) 04/2002
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2002

Drug/Important Bio-Agent (IBA)

3	RNA (Ribonucleic Acid)IBA 02/2024 - 09/2015
2	Proteins (Proteins, Gene)FDA Link 02/2024 - 11/2012
2	phosphine (phosphane)IBA 01/2020 - 01/2015
2	CholesterolIBA 01/2013 - 01/2012
2	fludarabineIBA 01/2003 - 02/2002
1	Biomarkers (Surrogate Marker)IBA 02/2024
1	fipronilIBA 01/2022
1	InsecticidesIBA 01/2022
1	decamethrin (deltamethrin)IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 04/2021
1	Air Pollutants (Pollutants, Air)IBA 12/2020
1	Peracetic Acid (Peroxyacetic Acid)IBA 12/2019
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 12/2019
1	Agammaglobulinaemia Tyrosine KinaseIBA 03/2014
1	ibrutinibIBA 03/2014
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 11/2012
1	ParaffinIBA 07/2012
1	Formaldehyde (Formol)FDA Link 07/2012
1	SMARCB1 ProteinIBA 07/2012
1	Dihydrotachysterol (AT 10)IBA 01/2012
1	Carbon MonoxideIBA 01/2010
1	AntioxidantsIBA 01/2010
1	AllergensIBA 01/2010
1	Shellfish ProteinsIBA 01/2010
1	metabisulfiteIBA 01/2010
1	Alemtuzumab (Campath)FDA Link 05/2004
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2003
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2003
1	Antisense OligonucleotidesIBA 01/2003
1	oblimersen (G3139)IBA 01/2003
1	ElectrolytesIBA 01/2003
1	Rituximab (Mabthera)FDA Link 02/2002
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 02/2002
1	Complement System Proteins (Complement)IBA 02/2002
1	Caspase 3 (Caspase-3)IBA 02/2002
1	Monoclonal AntibodiesIBA 02/2002
1	CaspasesIBA 02/2002
1	Caspase 9IBA 02/2002

Therapy/Procedure

4	Therapeutics 04/2021 - 05/2004
3	Radiotherapy 07/2015 - 04/2002
2	Drug Therapy (Chemotherapy) 01/2003 - 02/2002
2	Aftercare (After-Treatment) 04/2002 - 02/2002
1	Image-Guided Radiotherapy 07/2015
1	Brachytherapy 10/2002
1	Combined Modality Therapy 10/2002